Published in
Springer Nature [academic journals on nature.com], Blood Cancer Journal, 6(12), 2022
DOI: 10.1038/s41408-022-00691-9
Links
Tools
Clinical outcome of myelodysplastic syndrome progressing on hypomethylating agents with evolving frontline therapies: continued challenges and unmet needs
Journal article published in 2022 by
Ahmad Ghorab 
,
Aref Al-Kali ,
Michelle Elliot,
Naseema Gangat ,
Hasan Alkhateeb ,
Mithun Shah ,
Yuanhang Liu,
Cecilia Arana Yi,
Hemant Murthy,
Mohamed Kharfan-Dabaja ,
Ayalew Tefferi ,
Mrinal Patnaik ,
Mark Litzow,
Talha Badar
,
Aref Al-Kali ,
Michelle Elliot,
Naseema Gangat ,
Hasan Alkhateeb ,
Mithun Shah ,
Yuanhang Liu,
Cecilia Arana Yi,
Hemant Murthy,
Mohamed Kharfan-Dabaja ,
Ayalew Tefferi ,
Mrinal Patnaik ,
Mark Litzow,
Talha Badar
This paper is made freely available by the publisher.
Full text: Download
Postprint:
archiving forbidden
Data provided by 